242 related articles for article (PubMed ID: 28856858)
1. Enhancing ablation effects of a microbubble contrast agent on high-intensity focused ultrasound: an experimental and clinical study.
Cheng C; Xiao Z; Huang G; Zhang L; Bai J
BJOG; 2017 Aug; 124 Suppl 3():78-86. PubMed ID: 28856858
[TBL] [Abstract][Full Text] [Related]
2. Enhancing ablation effects of a microbubble-enhancing contrast agent ("SonoVue") in the treatment of uterine fibroids with high-intensity focused ultrasound: a randomized controlled trial.
Jiang N; Xie B; Zhang X; He M; Li K; Bai J; Wang Z; He J; Zhang L
Cardiovasc Intervent Radiol; 2014 Oct; 37(5):1321-8. PubMed ID: 24549267
[TBL] [Abstract][Full Text] [Related]
3. Effects of a microbubble ultrasound contrast agent on high-intensity focused ultrasound for uterine fibroids: a randomised controlled trial.
Chen Y; Jiang J; Zeng Y; Tian X; Zhang M; Wu H; Zhou H
Int J Hyperthermia; 2018 Dec; 34(8):1311-1315. PubMed ID: 29301450
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of a microbubble-enhancing contrast ("SonoVue") in treatment of uterine fibroids with high intensity focused ultrasound: a retrospective study.
Peng S; Xiong Y; Li K; He M; Deng Y; Chen L; Zou M; Chen W; Wang Z; He J; Zhang L
Eur J Radiol; 2012 Dec; 81(12):3832-8. PubMed ID: 22613505
[TBL] [Abstract][Full Text] [Related]
5. Using microbubble sonographic contrast agent to enhance the effect of high intensity focused ultrasound for the treatment of uterine fibroids.
Isern J; Pessarrodona A; Rodriguez J; Vallejo E; Gimenez N; Cassadó J; De Marco JA; Pedrerol A
Ultrason Sonochem; 2015 Nov; 27():688-693. PubMed ID: 26113390
[TBL] [Abstract][Full Text] [Related]
6. Microbubble contrast agent SonoVue combined with oxytocin improves the efficiency of high-intensity focused ultrasound ablation for adenomyosis.
Yao R; Zhao W; Gao B; Hu J; Wang T
Int J Hyperthermia; 2021; 38(1):1601-1608. PubMed ID: 34763594
[TBL] [Abstract][Full Text] [Related]
7. Intraprocedure contrast enhanced ultrasound: the value in assessing the effect of ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids.
Peng S; Hu L; Chen W; Chen J; Yang C; Wang X; Zhang R; Wang Z; Zhang L
Ultrasonics; 2015 Apr; 58():123-8. PubMed ID: 25627929
[TBL] [Abstract][Full Text] [Related]
8. Effect of microbubble contrast agent during high intensity focused ultrasound ablation on rabbit liver in vivo.
Chung DJ; Cho SH; Lee JM; Hahn ST
Eur J Radiol; 2012 Apr; 81(4):e519-23. PubMed ID: 21708438
[TBL] [Abstract][Full Text] [Related]
9. Clinical Usefulness of the Microbubble Contrast Agent SonoVue in Enhancing the Effects of High-Intensity Focused Ultrasound for the Treatment of Adenomyosis.
Jingqi W; Lu Z; Jun Z; Yuhong M; Wei Y; Lifeng R; Chengbing J; Dobromir DD; Hui Z; Kun Z
J Ultrasound Med; 2018 Dec; 37(12):2811-2819. PubMed ID: 29689636
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic response assessment of high intensity focused ultrasound therapy for uterine fibroid: utility of contrast-enhanced ultrasonography.
Zhou XD; Ren XL; Zhang J; He GB; Zheng MJ; Tian X; Li L; Zhu T; Zhang M; Wang L; Luo W
Eur J Radiol; 2007 May; 62(2):289-94. PubMed ID: 17258417
[TBL] [Abstract][Full Text] [Related]
11. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
Lee JS; Hong GY; Lee KH; Kim TE
BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
[TBL] [Abstract][Full Text] [Related]
12. Combination of HIFU with sulfur hexafluoride microbubbles in the treatment of solitary uterine fibroids: a systematic review and meta-analysis.
Jin J; Zhao Y; Huang P
Eur Radiol; 2023 Nov; ():. PubMed ID: 37950765
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound guided high intensity focused ultrasound (USgHIFU) ablation for uterine fibroids: Do we need the microbubbles?
Orsi F; Monfardini L; Bonomo G; Krokidis M; Della Vigna P; Disalvatore D
Int J Hyperthermia; 2015 May; 31(3):233-9. PubMed ID: 25758436
[TBL] [Abstract][Full Text] [Related]
14. Feasibility, Safety, and Efficacy of Accurate Uterine Fibroid Ablation Using Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound With Shot Sonication.
Xu Y; Fu Z; Yang L; Huang Z; Chen WZ; Wang Z
J Ultrasound Med; 2015 Dec; 34(12):2293-303. PubMed ID: 26518278
[TBL] [Abstract][Full Text] [Related]
15. Application of dexmedetomidine-remifentanil in high-intensity ultrasound ablation of uterine fibroids: a randomised study.
Fu X; Huang F; Chen Y; Deng Y; Wang Z
BJOG; 2017 Aug; 124 Suppl 3():23-29. PubMed ID: 28856857
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of performing Sonazoid-based contrast-enhanced ultrasonography before ablation of uterine fibroids by high-intensity focused ultrasound: A preliminary cohort study.
Zhang L; Kim TH; Zhou K; Ran L; Yang W; Zhu H
Medicine (Baltimore); 2021 Jan; 100(2):e24064. PubMed ID: 33466163
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcomes in patients with uterine fibroids treated with ultrasound-guided high-intensity focused ultrasound.
Zou M; Chen L; Wu C; Hu C; Xiong Y
BJOG; 2017 Aug; 124 Suppl 3():30-35. PubMed ID: 28856864
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus.
Zhang L; Chen WZ; Liu YJ; Hu X; Zhou K; Chen L; Peng S; Zhu H; Zou HL; Bai J; Wang ZB
Eur J Radiol; 2010 Feb; 73(2):396-403. PubMed ID: 19108974
[TBL] [Abstract][Full Text] [Related]
19. Enhancing effects of SonoVue, a microbubble sonographic contrast agent, on high-intensity focused ultrasound ablation in rabbit livers in vivo.
Luo W; Zhou X; Ren X; Zheng M; Zhang J; He G
J Ultrasound Med; 2007 Apr; 26(4):469-76. PubMed ID: 17384044
[TBL] [Abstract][Full Text] [Related]
20. Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids.
Kim YS; Kim TJ; Lim HK; Rhim H; Jung SH; Ahn JH; Lee JW; Kim BG
Eur Radiol; 2017 Sep; 27(9):3956-3965. PubMed ID: 28210800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
